Should CKD EPI equation be used for estimation of glomerular filtration rate in obese subjects?

Kidney and Blood Pressure Research

Research Article

Open Access Gateway Domislovic M. · Domislovic V. · Fucek M. · Jelakovic A. · Gellineo L. · Dika Z. · Jelakovic B.
Abstract

Introduction: Pandemic of obesity is strongly related to increase of chronic kidney disease (CKD) prevalence. Currently recommended CKD EPI equation has several serious limitations particularly in obese subjects who have high body surface area (BSA). The aim of our study was to analyze differences in the prevalence of CKD between CKD EPI and de-indexed equations where individual BSA was used. Methods: In total of 2058 subjects (random sample from general rural population, 29.65% obese) BSA was estimated using Dubois&Dubois and Moesteller equations and included into the de-indexed equations (CKD Di, CKD Mi). CKD was classified according to the KDIGO guidelines and glomerular hyperfiltration (GHF) was defined as 95th percentile according the gender and age decade. Results: In obese subjects, prevalence of CKD was significantly higher with CKD EPI than with CKD Di and CKD Mi equations (9.5%, 6.1%, 5.3%, respectively; p

The Author(s). Published by S. Karger AG, Basel

Article / Publication Details Open Access License / Drug Dosage / Disclaimer This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

留言 (0)

沒有登入
gif